PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A systematic review and meta-analysis of six RCTs (1,857 participants) assessed the efficacy and safety of Eucalyptus for relieving cough, though most studies used combination formulations [PMID:35294302].
A systematic review explored the antibacterial properties of Eucalyptus globulus essential oil against methicillin-resistant Staphylococcus aureus (MRSA) [PMID:36978341].
In normal and diabetic rats, Eucalyptus globulus leaves were evaluated for the treatment of systemic infection with Candida albicans [PMID:21079663].
Eucalyptus globulus hydrosol and essential oil showed protective effects against bleomycin-induced pulmonary fibrosis in rats [PMID:35834630].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36978341 (2023) — Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review. · Antibiotics (Basel, Switzerland)
- 2.PMID: 37010839 (2023) — Safety Assessment of Eucalyptus globulus (Eucalyptus)-Derived Ingredients as Used in Cosmetics. · International journal of toxicology
- 3.PMID: 7546549 (1995) — Eucalyptone from Eucalyptus globulus. · Phytochemistry
- 4.PMID: 35420422 (2022) — New Monoterpene Acid and Gallic Acid Glucose Esters with Anti-Inflammatory Activity from Blue Gum (Eucalyptus globulus) Leaves. · Journal of agricultural and food chemistry
- 5.PMID: 35294302 (2022) — Efficacy and Safety of Eucalyptus for Relieving Cough: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.